Natalizumab	FCGR1A	
GRB2	CD19	
Rituximab	MS4A1	
WAS	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Rituximab	FCGR2C	
Rituximab	C1QC	
Alemtuzumab	FCGR2B	
FCGR2B	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
GRB2	WIPF1	
Alemtuzumab	C1QC	
Rituximab	FCGR3A	
GRB2	SPTA1	
MS4A1	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Alemtuzumab	FCGR2C	
Alemtuzumab	FCGR3B	
Alemtuzumab	C1QA	
Aminosalicylic Acid	CHUK	
IGHV2-5	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Natalizumab	ITGA4	
GRB2	NRAS	
FCGR2A	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Rituximab	FCGR1A	
GRB2	TFRC	
Alemtuzumab	FCGR2A	
NFKB2	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Natalizumab	C1QB	
FCGR3A	Autoimmune hemolytic anemia	
NFKB1	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
SPTB	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Rituximab	FCGR3B	
FCGR1A	FCGR3A	
WIPF1	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
TFRC	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Natalizumab	FCGR3A	
FCGR2C	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
GRB2	IL2RA	
IL2RA	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Rituximab	FCGR2B	
Pegademase bovine	GRB2	
Aminosalicylic Acid	ALOX5	
FCGR2A	FCGR3A	
Natalizumab	FCGR2C	
GRB2	SPTB	
GRB2	WAS	
GRB2	CD3G	
FCGR1A	CD3G	
FCGR3B	Autoimmune hemolytic anemia	
CD19	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Rituximab	FCGR2A	
Aminosalicylic Acid	PTGS2	
Natalizumab	ICAM1	
Aminosalicylic Acid	PLA2G2E	
Rituximab	C1R	
NRAS	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Rituximab	C1QB	
Alemtuzumab	FCGR3A	
IGHV2-5	Autoimmune hemolytic anemia	
GRB2	IGHV2-5	
MS4A1	Autoimmune hemolytic anemia	
Natalizumab	C1QC	
CHUK	NFKB2	
Rituximab	C1S	
CTLA4	Autoimmune hemolytic anemia	
Natalizumab	FCGR2B	
Natalizumab	FCGR3B	
Natalizumab	C1QA	
FCGR2A	IGHV2-5	
Natalizumab	FCGR2A	
PTGS2	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Alemtuzumab	C1QB	
ICAM1	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
FCGR3A	FCGR2A	
ICOS	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Aminosalicylic Acid	MPO	
FCGR1A	IGHV2-5	
CHUK	NFKB1	
CD3G	Autoimmune hemolytic anemia	
CD3G	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
FCGR2A	CD3G	
Alemtuzumab	C1R	
GRB2	ICOS	
Alemtuzumab	FCGR1A	
FCGR3A	CD3G	
FCGR3A	IGHV2-5	
SPTA1	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	
Natalizumab	C1R	
FCGR1A	FCGR2A	
Rituximab	C1QA	
Ipilimumab	CTLA4	
Alemtuzumab	CD52	
